Hyperbaric Oxygen for COVID-19 Patients

Stopped early · Not applicable

Conditions studied: COVID-19

In brief

Hyperbaric oxygen therapy (HBOT) treatment will be provided to patients as an adjunct to standard therapy for a cohort of 40 COVID19-positive patients with respiratory distress at NYU Winthrop Hospital. All patients prior to the clinical application of HBOT will be evaluated by the primary care team and hyperbaric physician. After the intervention portion of this study, a chart review will be performed to compare the outcomes of intervention patients versus patients who received standard of care.

Key facts

Study ID

NCT04332081

Run by

NYU Langone Health

People needed

80

Starts

2020-04-06

Expected to finish

2020-05-29

Last updated by the study team

2021-06-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• In order to be eligible to participate in this study, an individual must meet all of the following criteria:
• Male or female, age > 18 years
• Positive COVID 19 test
• Respiratory compromise defined by SpO2 <93%
• Ability to sign informed consent

You may not qualify if…

• An individual who meets any of the following criteria will be excluded from participation in this study:
• Pregnancy
• Untreated Pneumothorax

Where it is running

• NYU Winthrop Hospital — Mineola, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.